DLGAP1-AS4

Across TCGA pan-cancer cohorts, DLGAP1-AS4 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of DLGAP1-AS4’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where DLGAP1-AS4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DLGAP1-AS4 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

HNSC, BLCA, and KIRC are the cancer types where DLGAP1-AS4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DLGAP1-AS4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.060	.003	8	view →
BLCA	Female	IV	+0.123	.032	4	view →
KIRC	All	II,III,IV	−0.017	.033	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

DLGAP1-AS4–HNSC

Open the HNSC breakdown →